Goal and Learning Outcomes

The goal of this course is to educate nursing professionals, pharmacists, and providers on therapies for stroke prevention in atrial fibrillation. 
After taking this course, you should be able to:
  • Describe the general pathophysiology, classifications, symptoms, and risk factors for atrial fibrillation and the connection between atrial fibrillation and stroke.
  • Compare pharmacological and nonpharmacological therapies approved for use in atrial fibrillation to reduce the risk of stroke.
  • Recognize areas of practice where nurses, providers, and pharmacists can work together to optimize the use of therapies for preventing stroke in patients with atrial fibrillation.

Course Authors

Accreditation Information


In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791



Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses


Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.



None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.